To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. Our first job is to listen to and observe what our customers need, and meet those needs with quality products and services. While we are not currently experiencing delays due to this pandemic, we expect that we could see them as the situation evolves. If you experience any issues, please contact ATCC Customer Service at For Technical questions please contact Thank you for your understanding, patience and flexibility as ATCC does everything it can to help reduce the impact of the coronavirus pandemic to our valued customers.

CRISPR-edited Isogenic Cell Models Video

CRISPR/Cas9 genome editing technology is one of the most outstanding scientific breakthroughs in recent years, revolutionizing basic and medical research by enabling site-specific genome engineering of cell lines.

ATCC has mastered the science and art of CRISPR gene-editing. We take highly authenticated cell lines from our collection and introduce disease-relevant mutations using the CRISPR/Cas9 system to modify regions of interest in the genome, and then rigorously screen the gene-edited isogenic cell clones.

ATCC CRISPR gene-edited cell lines are:

  • Precisely gene edited
  • Engineered on commonly used tumor cell lines
  • Highly relevant to diseases and drug targets
  • Validated at genomic, transcript, and protein levels
  • Biofunctional characterization with specific inhibitors
  • Well suited for drug screening applications